Entera Bio Ltd.
SEC CIK 1638097 · [ENTX] · last insider filing 2026-05-08
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Germano Geno J | Director | filed 2026 - 2026 |
| Ellis Sean | Director | filed 2022 - 2026 |
| Rubin Steven D | Director | filed 2026 - 2026 |
| Taitel Haya | Director | filed 2023 - 2026 |
| Lieberman Gerald M | Director | filed 2022 - 2026 |
| Ostrov Gerald M | Director | filed 2022 - 2026 |
| Malca Yonatan | Director | filed 2022 - 2026 |
| Toledano Miranda Jayne | Director · Chief Executive Officer | filed 2022 - 2025 |
| Garceau Roger | Director | filed 2022 - 2024 |
| Mayron Ron | Director | filed 2022 - 2024 |
| Schwartz Phillip | Director · President of R&D | filed 2022 - 2022 |
| Jamas Spiros | Director · Chief Executive Officer | filed 2022 - 2022 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Galitzer Hillel | Chief Operating Officer | filed 2022 - 2026 |
| Yaacov-Garbeli Dana | Israel CFO | filed 2022 - 2026 |
| Burshtein Gregory | Chief of R&D | filed 2024 - 2026 |
| Gautam Leslie Velka | Chief Business Officer | filed 2025 - 2025 |
| Santora Arthur C II | Chief Medical Officer | filed 2022 - 2023 |
| Ratan Ramesh | U.S.based CFO | filed 2022 - 2022 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.